Prevalence and Prognostic Impact of Allelic Imbalances Associated with Leukemic Transformation of Philadelphia Chromosome-Negative Myeloproliferative Neoplasms

被引：0
|
作者：
Thoennissen, Nils Heinrich [1 ]
Krug, Utz O. [2 ]
Lee, Dhong Hyun [1 ]
Kawamata, Norohiko [1 ]
Lasho, Terra L. [3 ]
Weiss, Tamara [4 ]
Nowak, Daniel [1 ]
Iwanski, Gabriela B. [1 ]
Kato, Motohiro
Shih, Lee-Yung [6 ]
Koren-Michowitz, Maya [1 ]
Nagler, Arnon [7 ]
Raynaud, Sophie [8 ]
Mueller-Tidow, Carsten [2 ]
Mesa, Ruben A. [9 ]
Haferlach, Torsten [4 ]
Gilliland, D. Gary [10 ]
Tefferi, Ayalew [3 ]
Ogawa, Seishi [5 ]
Koeffler, H. Phillip
机构：
[1] Univ Calif Los Angeles, Sch Med, Div Hematol & Oncol, Cedars Sinai Med Ctr, Los Angeles, CA USA
[2] Univ Munster, Dept Internal Med Hematol Oncol, Munster, Germany
[3] Mayo Clin, Rochester, MN USA
[4] MLL Munich Leukemia Lab, Munich, Germany
[5] Univ Tokyo, Cncer Genom Project, Tokyo, Japan
[6] Chang Gung Univ, Chang Gung Mem Hosp, Taipei, Taiwan
[7] Chaim Sheba Med Ctr, Div Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel
[8] Archet Hosp, Cytogenet Lab, Nice, France
[9] Mayo Clin, Scottsdale, AZ USA
[10] Merck Res Labs, Boston, MA USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：525 / 525
页数：1
相关论文
共 50 条
  • [41] Calreticulin Mutations in Philadelphia Chromosome Negative Myeloproliferative Neoplasms
    Gulbay, Gonca
    Bar, Harika Gozukara
    Yesilada, Elif
    Erkurt, Mehmet Ali
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2022, 32 (02): : 75 - 80
  • [42] JAK2 exon 12 mutations in patients with Philadelphia(Ph) chromosome-negative myeloproliferative neoplasms
    王婕妤
    ChinaMedicalAbstracts(InternalMedicine), 2012, 29 (04) : 234 - 234
  • [43] Genetic polymorphisms and expression of NLRP3 inflammasome-related genes are associated with Philadelphia chromosome-negative myeloproliferative neoplasms
    Zhou, Ying
    Yan, Shuxin
    Liu, Na
    He, Na
    Zhang, Amin
    Meng, Sibo
    Ji, Chunyan
    Ma, Daoxin
    Ye, Jingjing
    HUMAN IMMUNOLOGY, 2020, 81 (10-11) : 606 - 613
  • [44] Pegylated interferon therapy for patients with Philadelphia chromosome-negative myeloproliferative disorders
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop M.
    Giles, Francis
    Verstovsek, Srdan
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (04): : 409 - 416
  • [45] Philadelphia chromosome-negative myeloproliferative neoplasms in younger adults: A critical discussion of unmet medical needs, with a focus on pregnancy
    Sant'Antonio, Emanuela
    Borsani, Oscar
    Camerini, Chiara
    Botta, Cirino
    Santoro, Marco
    Allegra, Alessandro
    Siragusa, Sergio
    BLOOD REVIEWS, 2022, 52
  • [46] The mutation profile of JAK2 and CALR in Chinese Han patients with Philadelphia chromosome-negative myeloproliferative neoplasms
    Zhiyuan Wu
    Xinju Zhang
    Xiao Xu
    Yuming Chen
    Tingting Hu
    Zhihua Kang
    Shibao Li
    Hua Wang
    Weiwei Liu
    Xiaochao Ma
    Ming Guan
    Journal of Hematology & Oncology, 7
  • [47] Chronic myeloid leukemia (CML) evolves from Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs) with unexpected frequency
    Michael J. Hochman
    B. Douglas Smith
    Theodoros Karantanos
    Evan M. Braunstein
    Ivana Gojo
    Tania Jain
    Michael B. Streiff
    Alison R. Moliterno
    Amy E. DeZern
    International Journal of Hematology, 2023, 117 : 456 - 462
  • [48] Covert Brain Infarcts in Patients with Philadelphia Chromosome-Negative Myeloproliferative Disorders
    Kuznetsova, Polina I.
    Raskurazhev, Anton A.
    Konovalov, Rodion N.
    Krotenkova, Marina V.
    Chechetkin, Andrey O.
    Lagoda, Olga V.
    Melikhyan, Anait L.
    Tanashyan, Marine M.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (01)
  • [49] Impact of Comorbidities and Response to Treatment on the MPN SAF Assessment of Philadelphia Chromosome-Negative Myeloproliferative Syndromes
    Ramdoun, Amina
    Hadjeb, Asma
    Chereti, Malika
    Benichou, Soraya
    Zouaoui, Zahia
    Benlazar, Sidi Mohamed El Amine
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S324 - S325
  • [50] CREB3L1 overexpression as a potential diagnostic marker of Philadelphia chromosome-negative myeloproliferative neoplasms
    Morishita, Soji
    Yasuda, Hajime
    Yamawaki, Saya
    Kawaji, Hideya
    Itoh, Masayoshi
    Edahiro, Yoko
    Imai, Misa
    Kogo, Yasushi
    Tsuneda, Satoshi
    Ohsaka, Akimichi
    Hayashizaki, Yoshihide
    Ito, Masafumi
    Araki, Marito
    Komatsu, Norio
    CANCER SCIENCE, 2021, 112 (02) : 884 - 892
12345